The liver in systemic amyloidosis: Insights from 123I serum amyloid P component scintigraphy in 484 patients

Gut

Volumn 42, Issue 5, 1998, Pages 727-734

  Lovat, L B ^a   Persey, M R ^a   Madhoo, S ^a   Pepys, M B ^a   Hawkins, P N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Serum amyloid P component; Systemic amyloidosis

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; IODINE 123; SERUM AMYLOID P;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LIVER DISEASE; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL;

EID: 0031810645     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.5.727     Document Type: Article

References (32)

1. Pepys MB. Amyloidosis. In: Frank MM, Austen KF, Claman HN, Unanue ER, eds. Samter's immunologic diseases. 5th edn. Boston: Little, Brown and Company, 1994:637-55.
2. 125I labeled serum amyloid P component. N Engl J Med 1990;323:508-13.
3. Hawkins PN, Wootton R, Pepys MB. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest 1990;86:1862-9.
4. Hawkins PN, Myers MJ, Lavender JP, et al. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988;i:1413-8.
5. Gertz MA, Kyle RA. Hepatic amyloidosis (primary (AL), immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988;85:73-80.
6. Stauffer MH, Gross JB, Foulk WT, et al. Amyloidosis: diagnosis with needle biopsy of the liver in eighteen patients. Gastroenterology 1961;41:92-6.
7. Volwiler W, Jones CM. The diagnostic and therapeutic value of liver biopsies: with particular reference to trocar biopsy. N Engl J Med 1947;237:651-6.
8. Iwata T, Hoshii Y, Kawano H, et al. Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins. Hum Pathol 1995;26:1148-53.
9. Levy M, Pollack A, Lender M, et al. The liver in amyloidosis. Digestion 1974;10:40-51.
10. Levine RA. Amyloid disease of the liver. Am J Med 1962;33: 349-57.
11. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 1997;25:118-21.
12. Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994;87:289-95.
13. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-64.
14. Wilkins J, Gallimore JR, Tennent GA, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Che, 1994;40:1284-90.
15. Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991;77: 257-62.
16. Persey MR, Lovat LB, Apperley JF, et al. Intensive chemotherapy for AL amyloidosis. Br J Rheumatol 1996; 35(suppl I):12.
17. Harrison R-F, Hawkins PN, Roche WR, et al. "Fragile" liver and massive hepatic haemorrhage due to hereditary amyloidosis. Gut 1996;38:151-2.
18. Hawkins PN, Richardson S, MacSweeney JE, et al. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med 1993;86:365-74.
19. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32:45-59.
20. Tan SY, Pepys MB, Hawkins PN. Treatment of amyloidosis. Am J Kidney Dis 1995;26:267-85.
21. Hutchinson WL, Mather SJ, Staltieri M, et al. Scintigraphic imaging of amyloid deposits with Tc-labelled serum amyloid P component. In: Kisilevsky R, Benson MD, Frangione B, Gauldic J, Muckle TJ, Young ID, eds. Amyloid and amyloidosis 1993. Pearl River, New York: Parthenon Publishing, 1994:682-4.
22. Totterman KJ, Manninen V. Tumefactive liver infiltration in amyloidosis. Ann Clin Res 1982;14:11-4.
23. Chopra S, Rubinow A, Koff RS, et al. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 1984;115:186-93.
24. Maury CP, Wegelius O. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis. Int J Tissue React 1985;7:405-7.
25. Mandelstam P, Simmons DE, Mitchell B. Regression of amyloid in Crohn's disease after bowel resection. J Clin Gastroenterol 1980;11:324-6.
26. Peters RA, Koukoulis G, Gimson A, et al. Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut 1994;35:1322-5.
27. Terada T, Hirata K, Hisada Y, et al. Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma. Histopathology 1994;24:485-7.
28. Lloreta J, Vadell C, Fabregat X, et al. Fibrolamellar hepatic tumor with neurosecretory features and systemic deposition of AA amyloid. Ultastruct Pathol 1994;18:287-92.
29. Fievet P, Sevestre H, Boudjelal M, et al. Systemic AA amyloidosis induced by liver cell adenoma. Gut 1990;31:361-3.
30. Okazaki K, Moriyasu F, Shiomura T, et al. Spontaneous rupture of the spleen and liver in amyloidosis a case report and review of the literature.Gastroenterol Jpn 1986; 21:518-24.
31. Ades CJ, Strutton GM, Walker NI, et al. Spontaneous rupture of the liver associated with amyloidosis. J Clin Gastroenterol 1989;11:85-7.
32. Gastineau DA, Gertz MA, Rosen CB, et al. Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis. Am J Hematol 1991;37:194-6.